28th Sep 2021 17:21
Yourgene Health PLC - Manchester, England-based diagnostics products firm - Non-Executive Chair Adam Reynolds at annual general meeting on Tuesday says company expects to report revenue of at least GBP15 million for half-year to September 30, up from GBP8.2 million a year ago. Welcomes easing of travel rules between UK and US, and says it is now operating at previously announced capacity of 100,000 tests per month.
"Our long-term strategy remains to build an international molecular diagnostics business of scale, and we have plans to redeploy Covid-generated funds into further enhancing our core Genomic Service and Genomic Technology business streams. We are maintaining a conservative approach to forecast guidance regarding Covid testing and other revenue, but will provide further updates as appropriate, as the second half progresses," says Reynolds.
Current stock price: 14.75 pence
Year-to-date change: flat
By Lucy Heming;Â [email protected]
Copyright 2021 Alliance News Limited. All Rights Reserved.
Related Shares:
YGEN.L